Astria Therapeutics Inc ATXS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/15/24 EDT
9.27UNCH (UNCH)
Volume
14,541
Close
9.27UNCH (UNCH)
Volume
618,395
52 week range
4.26 - 16.90
Loading...
  • Open9.64
  • Day High10.04
  • Day Low9.25
  • Prev Close9.49
  • 52 Week High16.90
  • 52 Week High Date03/25/24
  • 52 Week Low4.26
  • 52 Week Low Date11/17/23

Key Stats

  • Market Cap509.044M
  • Shares Out54.91M
  • 10 Day Average Volume0.76M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change20.7

KEY STATS

  • Open9.64
  • Day High10.04
  • Day Low9.25
  • Prev Close9.49
  • 52 Week High16.90
  • 52 Week High Date03/25/24
  • 52 Week Low4.26
  • 52 Week Low Date11/17/23
  • Market Cap509.044M
  • Shares Out54.91M
  • 10 Day Average Volume0.76M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change20.7

RATIOS/PROFITABILITY

  • EPS (TTM)-2.32
  • P/E (TTM)-3.99
  • Fwd P/E (NTM)-5.64
  • EBITDA (TTM)-93.687M
  • ROE (TTM)-42.03%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-10,122.80%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Astria Therapeutics Inc

 

Profile

MORE
Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. The Company's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Its second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment...
Kenneth Bate
Independent Chairman of the Board
Jill Milne Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Noah Clauser
Chief Financial Officer
Address
75 State Street, Suite 1400
Boston, MA
02109
United States

Top Peers

SYMBOLLASTCHG%CHG
CMPS
Compass Pathways PLC
8.28UNCHUNCH
CABA
Cabaletta Bio Inc
12.69UNCHUNCH
OLMA
Olema Pharmaceuticals Inc
9.85UNCHUNCH
CELC
Celcuity Inc
17.23UNCHUNCH
ALT
Altimmune Inc
8.87UNCHUNCH